首页> 美国卫生研究院文献>Nutrients >FlexPro MD® a Combination of Krill Oil Astaxanthin and Hyaluronic Acid Reduces Pain Behavior and Inhibits Inflammatory Response in Monosodium Iodoacetate-Induced Osteoarthritis in Rats
【2h】

FlexPro MD® a Combination of Krill Oil Astaxanthin and Hyaluronic Acid Reduces Pain Behavior and Inhibits Inflammatory Response in Monosodium Iodoacetate-Induced Osteoarthritis in Rats

机译:FlexProMD®是磷虾油虾青素和透明质酸的组合可减少痛觉并抑制碘乙酸单钠诱导的大鼠骨关节炎的炎症反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Osteoarthritis (OA) is a degenerative joint disease and a leading cause of adult disability. Since there is no cure for OA and no effective treatment to slow its progression, current pharmacologic treatments, such as analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), only alleviate symptoms, such as pain and inflammation, but do not inhibit the disease process. Moreover, chronic intake of these drugs may result in severe adverse effects. For these reasons, patients have turned to the use of various complementary and alternative approaches, including diverse dietary supplements and nutraceuticals, in an effort to improve symptoms and manage or slow disease progression. The present study was conducted to evaluate the anti-osteoarthritic effects of FlexPro MD (a mixture of krill oil, astaxanthin, and hyaluronic acid; FP-MD) in a rat model of OA induced by monosodium iodoacetate (MIA). FP-MD significantly ameliorated joint pain and decreased the severity of articular cartilage destruction in rats that received oral supplementation for 7 days prior to MIA administration and for 21 days thereafter. Furthermore, FP-MD treatment significantly reduced serum levels of the articular cartilage degeneration biomarkers cartilage oligomeric matrix protein (COMP) and crosslinked C-telopeptide of type II collagen (CTX-II), and the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6), as well as mRNA expression levels of inflammatory mediators, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and matrix-degrading enzymes, matrix metalloproteinase (MMP)-2 and MMP-9, in the knee joint tissue. Our findings suggest that FP-MD is a promising dietary supplement for reducing pain, minimizing cartilage damage, and improving functional status in OA, without the disadvantages of previous dietary supplements and medicinal agents, including multiple adverse effects.
机译:骨关节炎(OA)是一种退化性关节疾病,是成人残疾的主要原因。由于无法治愈OA,也没有有效的方法来减缓OA的发展,目前的药物治疗(例如镇痛药和非甾体抗炎药(NSAIDs))只能缓解症状,例如疼痛和炎症,但不能抑制疾病过程。此外,长期服用这些药物可能会导致严重的不良反应。由于这些原因,患者已转向使用各种补充和替代方法,包括各种饮食补充剂和营养保健品,以改善症状并控制或减慢疾病进展。进行本研究以评估FlexPro MD(磷虾油,虾青素和透明质酸的混合物; FP-MD)在碘乙酸单钠(MIA)诱导的OA大鼠模型中的抗骨关节炎作用。 FP-MD可以显着改善关节疼痛,并降低在MIA给药前7天和之后21天接受口服补给的大鼠的关节软骨破坏的严重性。此外,FP-MD治疗可显着降低关节软骨变性生物标记物软骨寡聚基质蛋白(COMP)和II型胶原交联的C-端肽(CTX-II)和促炎性细胞因子肿瘤坏死因子α(TNF)的血清水平-α),白介素-1β(IL-1β)和白介素-6(IL-6)以及炎症介质,诱导型一氧化氮合酶(iNOS)和环氧化酶2(COX-2)的mRNA表达水平,膝关节组织中的基质降解酶,基质金属蛋白酶(MMP)-2和MMP-9。我们的研究结果表明,FP-MD是一种有前途的膳食补充剂,可减轻疼痛,最大程度地减少软骨损害并改善OA的功能状态,而没有以前的膳食补充剂和药物的缺点,包括多种不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号